Purchase Order 75F40118P10042
Award Date
5/9/18
Potential Completion Date
5/3/19
Potential Value
$398K
Federal Agency
Food and Drug Administration
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Corporation
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
College Park, MD 20742, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
Bruker Biospin Corp, a manufacturer of scientific instruments, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $1,609,000. The contract calls for Bruker Biospin Corp to provide a 600 MHz Bruker nuclear magnetic resonance spectrometer to the agency's facility in Billerica, Massachusetts by December 31, 2022. No set-aside designation was used for this procurement. Bruker Corporation is the parent company of Bruker...
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the procurement of a 400MHz NMR spectrometer food screening system, under solicitation FDA-RFQ-CFSAN-2024-121654. The total ceiling value of the contract is $359,990.00, with a completion date of July 4, 2025. This award is not associated with a set-aside program. Bruker Biospin Corp is a manufacturer of scientific instruments and has a...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
This federal contract award is for an LAB INSTRUMENT CONTROLLER UPGRADE worth $6,500.00 issued by the Food and Drug Administration (FDA) to the prime contractor Bruker Biospin Corp. The contract is a Firm Fixed Price Purchase Order with a completion date of November 2, 2013. The award does not have a set-aside designation. Bruker Biospin Corp is a wholly owned subsidiary of the Bruker Corporation, a global scientific instrumentation company that provides a wide range of analytical and diagnostic...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...
This federal contract award, valued at $97,136.00, was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for upgrades and additional imaging equipment for an existing Bruker BioSpec 4.7 T 40 cm bore system with an Avance III console magnetic resonance imaging (MRI) system. The contract does not have a set-aside designation, indicating it was competitively awarded. Bruker Biospin Corp has extensive experience providing specialized...
This federal contract award was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for the procurement of a Quadruple Resonance Inverse (QCI) Detection Cryoprobe for high-field nuclear magnetic resonance (NMR) instrumentation. The contract, valued at $315,583.00, was awarded on a firm fixed-price basis without any set-aside designation. The award supports the FDA's 850 MHz Instrument Cryoprobe program, which focuses on advanced analytical...
The Department of Health and Human Services Food and Drug Administration awarded a $126,772 firm fixed price purchase order to Bruker Biospin Corp. to deliver a solid-state NMR probe. The place of performance is in Billerica, Massachusetts, with work expected to be completed by April 2024. Per the solicitation, the FDA requested quotes for a solid-state NMR probe to add to an existing 500-MHz instrument in order to expand its analytical capabilities. As the leading regulatory agency for ensuring...
The Department of Health and Human Services Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp. to deliver a 400 MHz Nuclear Magnetic Resonance Spectrometer with solid and liquid probes. The solicitation sought this high-resolution NMR equipment to characterize pharmaceutical ingredients, drugs, and excipients in both liquid and solid states at the agency's Silver Spring, Maryland location. Installation, training, and maintenance services...